August Heidland

August Heidland's AcademicInfluence.com Rankings

August Heidland

Philosophy

#8403

World Rank

#11782

Historical Rank

Logic

#5442

World Rank

#6844

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is August Heidland Influential?

(Suggest an Edit or Addition)

(See a Problem?)

August Heidland's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cancer in End-Stage Renal Disease: Potential Factors Involved (1998) (177)
Advanced glycation end products and the progressive course of renal disease. (2001) (170)
Inflammation and Oxidative Stress in Chronic Kidney Disease—Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites (2019) (151)
Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2). (2000) (132)
Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation. (2002) (121)
N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. (2001) (111)
Genotoxicity of advanced glycation end products in mammalian cells. (2003) (104)
Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. (1989) (102)
Renal disease in obesity: the need for greater attention. (2006) (99)
Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro (2008) (89)
Long-term effects of essential amino acids supplementation in patients on regular dialysis treatment. (1975) (89)
Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. (2001) (84)
Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. (1999) (83)
Release of granulocyte proteinases during hemodialysis. (1983) (82)
Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). (1995) (82)
Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor. (1986) (82)
Serum carboxymethyllysine predicts mortality in hemodialysis patients. (2006) (80)
Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function. (2007) (80)
Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet (2001) (79)
Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis. (1985) (79)
Blood rheology and hypertension in hemodialysis patients treated with erythropoietin. (1988) (77)
Plasma advanced glycation end products are decreased in obese children compared with lean controls. (2009) (74)
Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis. (2008) (70)
The contribution of Rudolf Virchow to the concept of inflammation: what is still of importance? (2006) (69)
Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality. (2002) (69)
Mono‐ and Divalent Electrolyte Patterns, pCO2 and pH in Relation to Flow Rate in Normal Human Parotid Saliva * (1972) (65)
Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. (2004) (63)
Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2). (2000) (60)
Proteolytic enzymes and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. (1983) (60)
Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians. (2006) (59)
Alcohol abuse: potential role in electrolyte disturbances and kidney diseases. (1998) (57)
Advanced Glycation End Products in End-Stage Renal Disease and Their Removal (2001) (57)
Proteases II. Potential role in health and disease. Proceedings of the second international conference. May 17-20, 1987, Rothenburg, Federal Republic of Germany. (2012) (57)
Disturbances of peripheral and autonomic nervous system in chronic renal failure: effects of hemodialysis and transplantation. (1985) (56)
Enhanced proteolytic activity--cause of protein catabolism in acute renal failure. (1980) (55)
Neuromuscular electrostimulation techniques: historical aspects and current possibilities in treatment of pain and muscle waisting. (2012) (55)
Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. (2007) (54)
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products (2003) (54)
Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study) (2018) (53)
Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis. (2000) (53)
Mechanisms and clinical significance of cell volume regulation. (1998) (53)
Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide antibodies. (1990) (52)
Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. (2008) (51)
Role of L-arginine-derived NO in ischemic acute renal failure in the rat. (1994) (51)
Plasma levels of advanced glycation end products in children with renal disease (2001) (51)
Genotoxicity of Advanced Glycation End Products: Involvement of Oxidative Stress and of Angiotensin II Type 1 Receptors (2005) (51)
Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease. (1996) (50)
Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. (2005) (49)
Effects of a diet rich in advanced glycation end products in the rat remnant kidney model. (2003) (49)
Autonomic Neuropathy in Chronic Renal Insufficiency (1985) (48)
Activation of leukocytes during prolonged physical exercise. (1988) (48)
Renal Effects of Oral Maillard Reaction Product Load in the Form of Bread Crusts in Healthy and Subtotally Nephrectomized Rats (2005) (47)
Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1. (1998) (47)
Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation. (1996) (46)
Dietary Bread Crust Advanced Glycation End Products Bind to the Receptor for AGEs in HEK‐293 Kidney Cells but Are Rapidly Excreted after Oral Administration to Healthy and Subtotally Nephrectomized Rats (2005) (46)
Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy. (1995) (46)
DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers (2016) (44)
Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists. (2010) (43)
Ototoxic side-effects of high doses of frusemide in patients with uraemia (1971) (43)
Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients (2008) (43)
Role of bradykinin in anaphylactoid reactions during hemodialysis with AN69 dialyzers. (1993) (43)
Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amosite (2008) (43)
Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis. (1993) (42)
Effect of cellular hydration on protein metabolism. (1997) (42)
Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related? (2001) (42)
The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats. (2011) (41)
Uraemic sympathetic neuropathy after haemodialysis and transplantation (1979) (41)
Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE inhibitor administration: potential role of lysosomal proteinases. (1995) (40)
Evaluation of essential amino acids and keto acids in uremic patients on low-protein diet. (1978) (39)
Evidence for the participation of granulocyte proteinases on intradialytic catabolism. (1984) (38)
Renal Effects of S18886 (Terutroban), a TP Receptor Antagonist, in an Experimental Model of Type 2 Diabetes (2007) (38)
Advanced Glycation End-Product Levels in Subtotally Nephrectomized Rats: Beneficial Effects of Angiotensin II Receptor 1 Antagonist Losartan (1999) (38)
Biochemical Assessment and Clinical Evaluation of a Bilirubin Adsorbent Column (Br-350) in Critically ILL Patients with Intractable Jaundice (1992) (36)
Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells. (1996) (36)
Effect of different hemodialysis regimens on genomic damage in end-stage renal failure. (2006) (36)
Incidence and spectrum of dialysis-associated cancer in three continents. (2000) (35)
Mesangial cell hypertrophy induced by NH4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH. (1998) (34)
Advanced oxidation protein products and advanced glycation end products in children and adolescents with chronic renal insufficiency. (2012) (33)
Diminished parathyroid gland responsiveness to hypocalcemia in diabetic patients with uremia. (1986) (32)
Decreased proteinase activity in isolated glomeruli of streptozotocin diabetic rats. (1989) (31)
[Incidence and spectrum of malignant disease among dialysis patients in North Bavaria]. (2002) (31)
Relation between Different Treatment Modalities and Genomic Damage of End-Stage Renal Failure Patients (2006) (30)
Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins (2010) (30)
Pilot study for comparison of reticulocyte-micronulei with lymphocyte-micronuclei in human biomonitoring. (2005) (30)
Effect of parathyroid hormone on elastase release from human polymorphonuclear leucocytes. (1989) (30)
Neuronal activation in the CNS during different forms of acute renal failure in rats (2009) (29)
Georg Ganter--a pioneer of peritoneal dialysis and his tragic academic demise at the hand of the Nazi regime. (2004) (29)
Plasma levels of main granulocyte components during hemodialysis. (1987) (28)
Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension (2001) (28)
[STOP-FLOW STUDIES ON THE ACTION MECHANISM OF FURSEMID]. (1964) (28)
Behaviour and hormonal status in healthy rats on a diet rich in Maillard reaction products with or without solvent extractable aroma compounds (2012) (28)
Neutrophil activation in acute renal failure and sepsis. (1990) (27)
Cytokine production by monocytes during haemodialysis. (1991) (27)
Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure. (2001) (26)
Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan. (1987) (26)
Genomic damage in end-stage renal failure: potential involvement of advanced glycation end products and carbonyl stress. (2004) (26)
Angiotensin-II-induced cell hypertrophy: potential role of impaired proteolytic activity in cultured LLC-PK1 cells. (1995) (26)
Treatment of the Anemia of Hemodialysis Patients with Recombinant Human Erythropoietin (1988) (25)
Impact of recombinant erythropoietin on sexual function in hemodialysis patients. (1989) (25)
Improved Immunoglobulin Production in Dialysis Patients Treated with Recombinant Erythropoietin (1992) (25)
Renal fibrosis: role of impaired proteolysis and potential therapeutic strategies. (1997) (25)
Increased Protein Glycation in Cirrhosis and Therapeutic Strategies to Prevent It (2005) (25)
Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin. (1989) (25)
Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1. (2001) (25)
High-tone external muscle stimulation in end-stage renal disease: effects on symptomatic diabetic and uremic peripheral neuropathy. (2008) (24)
Suppressing role of transforming growth factor-beta 1 on cathepsin activity in cultured kidney tubule cells. (1995) (24)
Inadvertent chlorpropamide hypoglycemia--no longer once in a blue moon? (1987) (24)
Toxic renal failure in the rat: beneficial effects of atrial natriuretic factor. (1986) (23)
Elimination of low molecular weight proteins during hemofiltration. (2008) (23)
Intraglomerular proteinase activity in adriamycin-induced nephropathy. (1992) (23)
Role of proteases in hypercatabolic patients with renal failure. (1983) (23)
Mass-screening for early detection of renal disease: benefits and limitations of self-testing for proteinuria. (2009) (22)
Neurotransmitters and neuropeptides in the baroreceptor reflex arc: connections between the nucleus of the solitary tract and the ventrolateral medulla oblongata in the rat. (1995) (21)
In vitro inhibition of protein catabolism by alpha 2-macroglobulin in plasma from a patient with posttraumatic acute renal failure. (1982) (21)
Advanced glycation endproducts and the kidney. (1998) (21)
Release of Leukocyte Elastase during Hemodialysis (1985) (20)
Atrial Natriuretic Factor in Specific Brain Areas of Spontaneously Hypertensive Rats (1988) (20)
High-Glucose Media Enhance the Responsiveness of Tubular Cells to Growth Promoters: Effect on Lysosomal Cathepsins and Protein Degradation (1998) (20)
Stimulation and inhibition of elastase release from human neutrophil-dependence on the calcium messenger system. (1987) (20)
Genomic damage in chronic renal failure--potential therapeutic interventions. (2005) (20)
Beneficial effect of proteases on allograft arteriosclerosis in a rat aortic model. (1996) (20)
Clinical Evaluation of a New High-Flux Cellulose Acetate Membrane (1989) (20)
Beta2-Mikroglobulin im Serum — ein Parameter des Glomerulumfiltrates* (1974) (19)
Proteases: potential role in health and disease. (1984) (19)
Release of leukocyte elastase during hemodialysis. Effect of different dialysis membranes. (1985) (19)
Neuronal Activation in the Central Nervous System of Rats in the Initial Stage of Chronic Kidney Disease-Modulatory Effects of Losartan and Moxonidine (2013) (19)
Release of granulocyte neutral proteinases in patients with acute and chronic renal failure. (1984) (18)
Influence of nitric oxide on renal function in toxic acute renal failure in the rat. (1996) (18)
Oxidative stress and non-enzymatic glycation in IgA nephropathy. (2005) (18)
Hypertension in chronic idiopathic glomerulonephritis: analysis of 311 biopsied patients (1989) (18)
Normalization of elevated prolactin levels in hemodialysis patients on erythropoietin. (1988) (18)
Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation (2004) (18)
Renal proteinases and kidney hypertrophy in experimental diabetes (1994) (18)
Urinary excretion of cathepsin B and cystatins as parameters of tubular damage. (1994) (18)
Effect of dialyzer geometry on granulocyte and complement activation. (1987) (18)
Advanced glycation end products impair protein turnover in LLC-PK1: amelioration by trypsin. (2001) (18)
[Therapy of renal anemia with recombinant human erythropoietin]. (2008) (18)
Autonomic neuropathy in chronic renal insufficiency. Comparative analysis of diabetic and nondiabetic patients. (1985) (17)
Toxic acute renal failure in the rat: effects of diltiazem and urodilatin on renal function. (1994) (17)
Toxic acute renal failure in the rat: effects of L-arginine and N-methyl-L-arginine on renal function. (1994) (17)
Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats. (2001) (17)
Uremic pneumonitis. Evidence for participation of proteolytic enzymes. (1984) (17)
Efficiency of 1-Year Treatment with Fluvastatin in Hyperlipidemic Patients with Nephrotic Syndrome (1999) (16)
Impaired proteolytic activity as a potential cause of progressive renal disease. (1996) (16)
Urine Analysis. Report on the Workshop Conference of the German Society for Clinical Chemistry and the Society of Nephrology in Würzburg, October 25 – 26, 1985 (1986) (16)
Is Vitamin D Deficiency Related to Accumulation of Advanced Glycation End Products, Markers of Inflammation, and Oxidative Stress in Diabetic Subjects? (2015) (15)
Atrial natriuretic peptide in gentamicin-induced acute renal failure. (1988) (15)
Catabolic factors in renal failure: therapeutic approaches. (1988) (15)
Effects of aldosterone and dexamethasone on atrial natriuretic peptide levels in preoptic and hypothalamic nuclei of adrenalectomized and intact rats. (1991) (15)
Hypertension as cause and consequence of renal disease in the 19th century. (1994) (15)
Toxic sympathicopathy in uraemia. (1973) (15)
The aging rat kidney displays low glomerular and tubular proteinase activities. (1994) (15)
Functional and Partial Morphological Regression of Established Renal Injury in the Obese Zucker Rat by Blockade of the Renin-Angiotensin System (2008) (14)
Improved function of B lymphocytes in dialysis patients treated by recombinant human erythropoietin. (1990) (14)
Evidence for reduced catabolism by the antiglucocorticoid RU 38486 in acutely uremic rats. (1987) (14)
New approaches for the treatment of genomic damage in end-stage renal disease. (2008) (14)
Severe Hypertensive Retinopathy (1987) (14)
Role of proteinases in renal hypertrophy and matrix accumulation. (1995) (14)
Reduction of urea generation and muscle protein degradation by adrenalectomy in acutely uremic rats. (1988) (14)
Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function. (1992) (14)
Effectiveness and Safety of Recombinant Human Erythropoietin (r-HuEPO) in the Treatment of Anemia of Chronic Renal Failure in Non Dialysis Patients (1994) (14)
The Selective TP Receptor Antagonist, S18886 (Terutroban), Attenuates Renal Damage in the Double Transgenic Rat Model of Hypertension (2007) (14)
Role of alcohol in clinical nephrology (1985) (14)
Effect of Chronic Therapy with Proteolytic Enzymes on Hypertension-Induced Renal Injury in the Rat Model of Goldblatt Hypertension (1998) (13)
Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients. (1995) (13)
Efficacy and safety of whole body vibration in maintenance hemodialysis patients - A pilot study (2017) (13)
Effect of different dialyzer membranes on plasma levels of granulocyte elastase. (1988) (13)
[Cochleo-vestibular disturbances in uremia in relation to electrolyte metabolism and the glomerular filtration rate]. (1972) (13)
Enhanced glycogen turnover in skeletal muscle of uremic rats--cause of uncontrolled actomyosin ATPase? (1978) (13)
Atrial natriuretic peptides in brain nuclei of rats with inherited diabetes insipidus (Brattleboro rats). (1990) (13)
[Hearing loss induced by the use of high doses of furosemide in the treatment of uremia]. (1970) (13)
25-hydroxyvitamin d and advanced glycation endproducts in healthy and hypertensive subjects: are there interactions? (2015) (12)
Evaluation of a new polyamide membrane (Polyflux 130) in high-flux dialysis. (1990) (12)
Elimination of low molecular weight proteins during hemofiltration. (1982) (12)
Changes in the central ANF-system of renovascular hypertensive rats. (1991) (12)
The flow-rate-dependent excretion of ionized calcium in human parotid saliva. (1979) (12)
Increased histidine and histamine content in the brain of chronic uremic rats. Cause of enhanced cerebral cyclic adenosine monophosphate in uremia? (1978) (12)
Atrial natriuretic factor content of brain nuclei in deoxycorticosterone acetate-salt hypertension in the rat. (1989) (12)
Suppressed Activities of Cathepsins and Metalloproteinases in the Chronic Model of Puromycin Aminonucleoside Nephrosis (1999) (12)
Homocysteine exerts genotoxic and antioxidative effects in vitro. (2007) (12)
Dialysis membranes inhibit in vitro release of beta-2-microglobulin from human lymphocytes. (1990) (12)
[Charcoal haemoperfusion in the treatment of sleeping-drug intoxication (author's transl)]. (1976) (12)
Effect of cryopreservation on DNA damage and DNA repair activity in human blood samples in the comet assay (2021) (11)
Depressor effect of saralasin in hypertensive crisis due to pheochromocytoma. (1977) (11)
High-tone external muscle stimulation in endstage renal disease: effects on quality of life in patients with peripheral neuropathy. (2012) (11)
Beginning of modern concept of inflammation: the work of Friedrich Daniel von Recklinghausen and Julius Friedrich Cohnheim. (2009) (11)
Neurotransmitter and monoaminergic amino acid precursor levels in rat brain: effects of chronic renal failure and of malnutrition. (1996) (11)
Improvement of dialyzer compatibility by reduction of membrane surface area. (1986) (11)
Atrial natriuretic peptide in the locus coeruleus and its possible role in the regulation of arterial blood pressure, fluid and electrolyte homeostasis. (1991) (11)
Technique of continuous collection of parotid saliva in the rat (1978) (11)
Role of glomerular proteinases in the evolution of glomerulosclerosis. (1992) (11)
DNA damage of lymphocytes in experimental chronic renal failure: beneficial effects of losartan. (2001) (11)
Alterations of water, electrolyte and acid-base homeostasis in the alcoholic. (1987) (10)
Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood mononuclear cells in vitro. (1991) (10)
Is the effect of calcium diet or parathyroidectomy on the development of hypertension in spontaneously hypertensive rats mediated by atrial natriuretic peptide? (1988) (10)
Effect of diuresis on urinary erythrocyte morphology in glomerulonephritis (1985) (10)
Normalization of enhanced hepatic gluconeogenesis by the antiglucocorticoid RU 38486 in acutely uraemic rats (1990) (10)
Deafness from furosemide. (1970) (10)
Change of elastase and cathepsin G content in polymorphonuclear leukocytes during hemodialysis. (1988) (10)
Human atrial natriuretic factor prevents against norepinephrine-induced acute renal failure in the rat. (1986) (10)
High-tone external muscle stimulation in patients with acute kidney injury (AKI): beneficial effects on NO metabolism, asymmetric dimethylarginine, and endothelin-1. (2014) (9)
[Increased cAMP concentration in parotid secretion in arterial hypertension: relationship to plasma-renin activity (author's transl)]. (1975) (9)
Effect of renal disease on glomerular proteinases. (1992) (9)
Chronic ethanol ingestion enhances catabolism and muscle protease activity in acutely uremic rats. (1988) (9)
Effects of protease therapy in the remnant kidney model of progressive renal failure. (1997) (9)
Calcium antagonists in the treatment of hypertension. (1983) (9)
Dose-dependent stimulation/inhibition effects of cyclosporin A on lysosomal cathepsin activities in cultured proximal tubule cells (1995) (9)
Uranyl nitrate-induced acute renal failure in rats: effect of atrial natriuretic peptide on renal function. (1988) (9)
Functional hyperhomocysteinemia in healthy vegetarians: no association with advanced glycation end products, markers of protein oxidation, or lipid peroxidation after correction with vitamin B(12). (2003) (9)
Mechanisms of acute uremic encephalopathy: early activation of Fos and Fra-2 gene products in different nuclei/areas of the rat brain. (2010) (9)
Atrial natriuretic factor in central nervous system regulatory mechanisms: effect of experimental alterations in water and salt homeostasis and blood pressure. (1990) (8)
Effects of urodilatin and diltiazem on renal function in ischemic acute renal failure in the rat. (1995) (8)
Carbohydrate metabolism in potassium-depleted rats. (1985) (8)
Jogger's leukocytes. (1987) (8)
Severe hypertensive retinopathy. Increased incidence in renoparenchymal hypertension. (1987) (8)
Haemorrhagic fever with renal syndrome, 1993: endemic or unrecognised pandemic? (1993) (8)
Effects of acetate during regular hemodialysis. (1988) (8)
[RENAL HEMODYNAMICS, WATER AND ELECTROLYTE ELIMINATION AFTER 4-CHLORO-N-(2-FURYLETHYL)-5-SULFAMOYLANTHRANILIC ACID]. (1964) (8)
Does Cadmium Contribute to the Development of Renal Parenchymal Hypertension? (1989) (8)
High-frequency external muscle stimulation in acute kidney injury (AKI): potential shortening of its clinical course. (2012) (8)
[Acute, reversible hearing damages due to rapid high-dosage furosemide infusions in terminal renal insufficiency]. (1970) (8)
Effect of low-protein diets on renal disease: are non-haemodynamic factors involved? (1995) (8)
Glycogen metabolism in muscle in uremia. (1980) (8)
Hypercatabolism in acute renal failure--mechanisms and therapeutical approaches. (1989) (8)
Effect of metabolic acidosis on tubular proteinase activity. (1994) (8)
Enhanced activity of sympathetic renal nerves in hypertensive patients with unilateral renal ischemia--its relationship to plasma renin activity in renal venous blood. (1993) (8)
[Increased cancer incidence in terminal kidney failure: potential pathogenetic mechanisms]. (1997) (7)
[Haemoperfusion with activated charcoal and ion exchanger in phalloidin intoxicated rats (author's transl)]. (1976) (7)
Comparative studies of guanfacine and methyldopa. (1980) (7)
Parathyroid hormone modulates the release of atrial natriuretic peptide during acute volume expansion. (1992) (7)
Contribution of Proteases to Hypercatabolism in Acute Renal Failure (1984) (7)
Leukocyte proteinases and proteinase inhibitors in the catabolism of acute renal failure. (1987) (7)
AT1 Receptor Antagonist Candesartan Attenuates Genomic Damage in Peripheral Blood Lymphocytes of Patients on Maintenance Hemodialysis Treatment (2011) (7)
Obese zucker rat: Potential role of intraglomerular proteolytic enzymes in the development of glomerulosclerosis (1991) (7)
[The pros and cons of haemoperfusion (author's transl)]. (1977) (7)
Proteases and other catabolic factors in renal failure. (1987) (7)
Protein restriction influences glomerular matrix turnover and tubular hypertrophy by modulation of renal proteinase activities. (1996) (7)
Proteolytic activity in patients with hypercatabolic renal failure. (1984) (7)
Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation (2022) (7)
Autonomic Neuropathy in Diabetic Nephropathy (1989) (7)
[Catecholamine content of adrenergic nerves in salivary glands with pathological electrolyte pattern in uremia. A fluorescence and enzyme histochemical study (author's transl)]. (1973) (7)
Circulatory changes during mental stress in tetraplegic and paraplegic man (1982) (7)
Cation Excretion and Kallikrein Secretion by the Rat Parotid Gland in Various Hypertensive Models (1984) (6)
The effect of oral protease administration in the rat remnant kidney model (1999) (6)
[Regulation of thirst in end-stage kidney insufficiency]. (1990) (6)
Abnormalities of glycogen metabolism in cardiomyopathy of phosphorous depletion. (1980) (6)
Haemodialysis in rats (1978) (6)
Proteinase activity in isolated glomeruli of Goldblatt hypertensive rats. (1991) (6)
Acute changes in cyclic AMP levels of certain brain areas following intraventricular injection of renin in rats (1982) (6)
The gluconeogenetic ability of hepatocytes in various types of acute uraemia. (1982) (6)
A simplified method for measurement of Ca++-activity in serum, using serum-monovettes® and a Ca++-selective disk-electrode (1978) (6)
[Studies on uremic sympathicopathy in vitro and in vivo]. (1973) (6)
Salivary kallikrein excretion in hypertension (1979) (6)
Studies on natriuretic properties of methylguanidine (1972) (6)
Clinical evaluation of the new, steam-sterilized polysulfone high-flux dialyzer. (1994) (6)
Abnormalities of carbohydrate metabolism in spontaneously hypertensive rats (1988) (6)
Effects of high doses of leucine and ketoleucine on glycogen and protein metabolism in acute uremia. (1980) (6)
Renal research in 19th century Germany. (2010) (6)
Glycogen metabolism in phosphorus-depleted rats. (1983) (6)
Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure (1981) (6)
Insulin-like growth factor I induced reduction in cysteine proteinase activity in freshly isolated proximal tubule cells of the rat. (1995) (6)
Acute and chronic renal effects of guanfacine in essential and renal hypertension. (1980) (6)
Effect of ACE inhibitors on atrial natriuretic factor in the brains of rats with reduced renal mass. (1993) (5)
Effects of parathyroid hormone on renal tubular proteinases. (1996) (5)
Stimulation and inhibition of elastase release from human neutrophils dependent on the calcium messenger system. (1987) (5)
Captopril--indications and clinical problems. (1984) (5)
Elimination of low molecular weight proteins during hemofiltration and CAPD. (1982) (5)
Serum growth factors in hemodialyzed patients. (2004) (5)
Retinopathy in hypertension. Increased incidence in renoparenchymal disease. (1987) (5)
[Value of post-operative parenteral nutrition as shown by various plasma protein measurements (author's transl)]. (1975) (5)
Psychomental stress in tetraplegic man: dissociation in autonomic variables and emotional responsiveness. (1984) (5)
[Overweight and obesity--risk factors in the development and progression of renal disease]. (2004) (5)
Beta-adrenergic blockade in stress protection. Limited effect of metoprolol in psychological stress reaction (1978) (5)
Reduction of muscle protein degradation by leupeptin in acutely uremic rats. (1988) (5)
The flow-rate-dependent excretion of ionized calcium in pilocarpine-stimulated human submandibular saliva. (1983) (5)
Intraglomerular fibronectin accumulation and degradation in obese Zucker rats (1991) (5)
Serum phospholipase A and prognosis in intensive care patients. (1990) (5)
Carbohydrate metabolism and uraemia — Mechanisms for glycogenolysis and gluconeogenesis (1980) (5)
Role of O-methylation in the renal excretion of catecholamines in dogs (2004) (5)
Plasma catecholamines in renal failure. (1986) (5)
Intracellular histidine content of various tissues (brain, striated muscle and liver) in experimental chronic renal failure (1977) (5)
Effect of hormones on hepatocyte gluconeogenesis in different models of acute uraemia. (1982) (4)
Effect of cyclosporin A, azathioprine, and prednisolone on carbohydrate metabolism of rat hepatocytes * (1990) (4)
[Increased levels of circulating advanced glycation end products in a model of acute renal insufficiency in rats]. (2001) (4)
Altered cAMP content in specific brain areas of spontaneously hypertensive rats dependent on calcium status or parathyroidectomy. (1986) (4)
[Collagen metabolism and mineralization of uremic bone--aspects of the molecular pathology of renal osteodystrophy]. (1976) (4)
Autonomic neuropathy in diabetic nephropathy. Effect of regular dialysis treatment and simultaneous transplantation of kidney and pancreas. (1989) (4)
Independence of enhanced protein catabolism from glucocorticoids in chronically uremic rats (1989) (4)
Atrial natriuretic factor in the subfornical organ and the organum vasculosum laminae terminalis. (1992) (4)
Angiotensin II-induced hypertension: effects on central and peripheral atrial natriuretic peptide. (1995) (4)
[Subcutaneous arteriovenous shunt for intermittent hemodialysis treatment]. (1967) (4)
The Renal Excretion of Nitrogen Containing Metabolites (1969) (4)
Evidence for Accumulation of Advanced Glycation End Products in Acute Renal Failure (2000) (4)
Influence of NH4CI on Polarized Release of Endogenous Protein Degradation Products and on Morphology in LLC-PK1 Cells (2000) (4)
Suppression of beta 2-microglobulin release from lymphocytes by dialysis membranes. (1991) (4)
[Hantavirus infections 1993: endemic or unrecognized pandemic?]. (1993) (4)
Effect of nifedipine on carbohydrate metabolism in the rat (1987) (4)
The role of magnesium and substances promoting the transport of electrolytes. (1973) (4)
The role of emeriti and retired professors in medicine. (2014) (4)
Evaluation of essential amino acids and (1978) (4)
Alterations in brain atrial natriuretic polypeptide levels in hypophysectomized rats. (1992) (4)
[Protein catabolism and tourniquet shock: the role of proteolytic enzymes]. (1982) (4)
Effect of cyclosporin A on carbohydrate metabolism of isolated rat liver cells. (1989) (4)
Reduced protein catabolism by the antiglucocorticoid RU 38486 in acutely uremic rats. (1989) (4)
Nutritional Management of the Uremic Patient (1991) (4)
Effect of β2-microglobulin on immunoglobulin production (1992) (4)
Intraglomerular fibronectin and laminin turn-over in chronically rejected kidney allografts in humans. (1996) (4)
[KIDNEY FUNCTION AFTER INFUSION OF LOW-MOLECULAR DEXTRAN]. (1965) (4)
[Potatoe egg diet and mixed low protein diet: subjective evaluation (author's transl)]. (1976) (3)
Glandular adenylate cyclase system in genetic hypertension: age-dependent response to catecholamines. (1988) (3)
Modulation of serum levels of sRAGE by bromelain in patients with chronic kidney disease: a pilot study. (2012) (3)
Retrospective diagnosis of small epidemic of haemorrhagic fever with renal syndrome (1992) (3)
Glandular adenylate cyclase system in genetic hypertension: age-dependent response to catecholamines (1988) (3)
Inactivation of urinary kallikrein by alpha1-antitrypsin (1981) (3)
[Secondary renal insufficiency, interstitial nephritis or tubular insufficiency following phenacetin abuse]. (1959) (3)
Treatment of renal tubular acidosis and osteomalacia by salidiuretics. (1973) (3)
Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients. (1992) (3)
[Hantavirus infection with acute kidney failure]. (1992) (3)
Adenylate cyclase-cyclic AMP-phosphodiesterase system in microdissected brain areas of normotensive and spontaneously hypertensive rats. (1989) (3)
5th Annual Meeting of the International Society of Blood Purification (1987) (3)
[Acute kidney failure caused by Hantaviruses]. (1994) (3)
Nutrition in acute renal failure. (1985) (3)
[Beta 2-microglobulin in the differential diagnosis of glomerular and tubular kidney diseases]. (1975) (3)
Prostacyclin (PGI2) induces rapid depletion of cyclic AMP levels in brain nuclei of rats. (1987) (3)
Rapid alterations in cAMP accumulation in brain nuclei of rats following microinjections of vasoactive intestinal polypeptide (VIP) into the lateral ventricle (1993) (3)
[The effect of sympathomimetric drugs on exocrine pancreatic function. Studies in the isolated cat pancreas (author's transl)]. (1977) (3)
[The influence of l-histidine substitution on protein metabolism (transferrin and complement system) and renal anaemia in endstage renal failure (author's transl)]. (1974) (3)
Human chronic kidney allograft rejection is accompanied by increased intraglomerular cathepsin B and L activity (1994) (3)
Systemic Proteolytic Enzyme Treatment Diminishes Urinary Interleukin 6 in Diabetic Patients (2000) (3)
[Saralasin in resistant hypertensive crisis (author's transl)]. (1979) (3)
Relationship between plasma level of parathyroid hormone and carboxymethyllysine in hemodialyzed patients--does it exist? (2003) (3)
Effects of centrally administered substance P on cyclic AMP levels in particular brain areas of rats. (1990) (3)
Suitability of non-glucose-carbohydrates for parenteral nutrition (1975) (3)
[Chemistry of saliva in primary hyperaldosteronism (Conn's syndrome)]. (1972) (3)
Serum ribonuclease activity in patients during parenteral nutrition, chronic hemodialysis and acute pancreatitis (1977) (3)
Karl Peter's fundamental contribution to the structural organization of the kidney. (2011) (3)
[Clinical experiences with subcutaneous arteriovenous shunt for hemodialysis treatment]. (1967) (3)
Enhanced parotid kallikrein secretion in essential, adrenal, and renoparenchymal hypertension and in advanced renal failure. (1980) (3)
Central atrial natriuretic peptide in dehydration. (2007) (3)
Catabolic effects of ethanol in chronically uremic rats. (1989) (2)
Angiotensin-converting enzyme inhibition in renal and hypertensive disorders. (1990) (2)
Heinrich Necheles: Pioneer of Hemodialysis in the Treatment of Experimental Uremia (2012) (2)
[Treatment of "therapy-resistant" forms of hypertension with captopril]. (1981) (2)
[Kidney and calcium metabolism. Physiology and pathophysiology of renal calcium excretion]. (1974) (2)
THE EFFECT OF PTH ON HUMAN PAROTID AND SUBMANDIBULAR SALIVA (1981) (2)
Defective hormonal stimulation of isolated hepatocytes in phosphorous depleted rats. (1982) (2)
Erythropoietin in the 90s (1990) (2)
Effect of diuretics and calcium antagonists on circulatory parameters and plasma catecholamines during mental stress (2004) (2)
Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients (1986) (2)
Participation of various brain nuclei in the altered time course of genetic hypertension in SHR dependent on changes in calcium metabolism. (1986) (2)
[Diagnosis of lactate acidosis]. (2008) (2)
Catabolism in acute renal failure: importance of glucocorticoids and lysosomal enzymes. (1987) (2)
[Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects]. (1992) (2)
Kallikrein-kinin system and hypertension. (1980) (2)
[Changes in renal function in heart failure and their modification by conversion enzyme inhibitors]. (1991) (2)
[Mental stress and sports. Does physical activity increase stress tolerance?]. (1983) (2)
[Hypocalcemia in malignant diseases]. (1983) (2)
BAEE esterase (kallikrein-like) activity in parotid saliva of normal rats and rats with various forms of experimental hypertension (genuine, renovascular and DOCA salt hypertension). (1980) (2)
Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function. (1988) (2)
Effect of disease on glomerular proteinases. (1992) (2)
Calcium antagonists: hypotensive and humoral actions in different forms of hypertension. (1985) (2)
[Renal phenolsulfonphthalein transport following dissociation of the dye-plasma binding due to sulfonomide]. (1968) (2)
Cancer in endstage renal failure: potential pathogenic factors. (1997) (2)
[beta2-Microglobulin in healthy children and in children with renal diseases (author's transl)]. (1975) (2)
[The influence of menstruation cycle on human parotid saliva composition (author's transl)]. (1979) (2)
Systemic treatment with proteolytic enzymes in rat models of nonimmune mediated renal diseases (1997) (2)
Report. Report of the seminar 'update in nephrology and hypertension' in Sofia (Bulgaria) (1998) (2)
Alterations in the adenylate cyclase‐cAMP‐phosphodiesterase system in the locus coeruleus during the development of spontaneous hypertension of the rat (1987) (2)
Bilateral Nephrectomy and Its Metabolic Consequences (1993) (2)
[Vigilance of patients with chronic renal insufficiency (author's transl)]. (1979) (2)
Acute renal failure following high intravenous doses of naftidrofuryloxalate. (1995) (2)
THE SECRETION OF IONISED AND TOTAL CALCIUM, PROTEIN AND INORGANIC PHOSPHATE BY THE SALIVARY GLANDS OF RAT AND MAN (1981) (2)
Hormonal regulation of muscle protein catabolism in acutely uremic rats: effect of adrenalectomy and parathyroidectomy. (1988) (2)
[Calcium antagonists in the therapy of hypertension]. (1983) (2)
Proteinase activity in isolated glomeruli of diabetic and non-diabetic rats. (1989) (2)
Report. International seminar 'Update in Nephrology and Hypertension', Brdo Kranju, Slovenia (1998) (2)
Lovastatin ameliorates depressed intraglomerular proteolytic activities in experimental nephrotic syndrome (1994) (2)
41 Renal Function During Mental Stress: Different Response in Normotensive and Hypertensive Subjects (1984) (2)
Effect of phosphate depletion on gluconeogenesis in isolated rat hepatocytes. (1984) (2)
[Urinary enzymes in essential hypertension and inflammatory kidney diseases]. (1972) (2)
Effect of dietary protein on glomerular proteinase activities. (1992) (2)
Role of urinary alpha1-antitrypsin in padutin® (kallikrein) inactivation (2004) (2)
[Prevention of the progression of chronic kidney failure]. (2008) (2)
[Plasma hydroxyproline in chronic renal failure (author's transl)]. (1976) (2)
Impairment of proteolytic activity in isolated glomeruli and tubules in experimental diabetic nephropathy. (1996) (2)
Seminars in Nephrology and Hypertension in Eastern Europe: Activities of the Kuratorium der Gesellschaft für Nephrologie (1996) (2)
Atrial natriuretic factor in brain areas of Dahl salt-sensitive and salt-resistant rats (1993) (2)
Intraglomerular cathepsin B and L activity in chronic kidney allograft rejection. (1995) (1)
Biocompatibility profile of the polysulfone 400 membrane. (1989) (1)
Glycogen synthesis from serine in isolated perfused hindquarters of acutely uraemic rats. (1983) (1)
[Raised cAMP content of striated muscle in experimental chronic renal failure (author's transl)]. (1975) (1)
Nonnutritional and nonhormonal methods to affect muscle strength and physical performance (2022) (1)
Effects of lisinopril on brain atrial natriuretic factor in uremic rats. (1992) (1)
[Beta2-microblogulin in serums: a measure of glomerular filtration]. (1974) (1)
Contents, Vol. 42, 1986 (1984) (1)
[Effect of the angiotensin-converting enzyme inhibitor ramipril on proteinuria, blood pressure and kidney function in histologically confirmed glomerulonephritis with nephrotic syndrome]. (1988) (1)
[Lactic acidosis--a possible complication in buformin-treated diabetics (author's transl)]. (1978) (1)
Retinopathy in Hypertension (1987) (1)
Effect of beta 2-microglobulin on immunoglobulin production. (1992) (1)
Long-term effects of nifedipine on plasma levels of 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D in hypertensive hemodialyzed patients (1986) (1)
[Increased cAMP excretion in the saliva, the "second messenger" of beta-adrenergic signal exchange, in etiologically different forms of hypertension]. (1975) (1)
Role of cadmium in hypertensive patients with renal parenchymal disease. (1989) (1)
Oxidative stress, advanced glycation end products and residual renal function in the rat model of unilateral ureteral obstruction: effects of phlogenzym and losartan (2010) (1)
[Antihypertensive treatment in kidney diseases: whom, with what, how intensively?]. (2009) (1)
[CLINICAL ASPECTS OF COCCIDIOMYCOSIS]. (1965) (1)
[Autonomic insufficiency in dialysis patients]. (1975) (1)
Protease therapy alleviates allograft arteriosclerosis in rats. (1996) (1)
Professor Tadeusz Orlowski – In Memory of a Pioneer in European Nephrology and Transplantation (2009) (1)
Enhanced plasma and intracellular levels of main granulocyte components in diabetics on dialysis. (1989) (1)
Effects of acute haemodialysis-induced changes in sodium balance upon experimentally hypertensive rats. (1980) (1)
[Flow rate-dependent excretion of electrolytes in human parotid and submandibular saliva after stimulation with pilocarpine and lemon juice]. (1982) (1)
[Effective kidney plasma flow and phenol red excretion in pyelonephritis and renal hypertension]. (1962) (1)
The legacy of Karl Julius Ullrich (1925-2010). (2013) (1)
[Saliva electrolytes and flow rate in the diagnosis of Bartter's syndrome, pseudo-Bartter's syndrome and Conn's syndrome]. (1972) (1)
[Tularemia, grave infectious disease in western Germany; with reference to an epidemic covering a small area in Schleswig-Holstein]. (1951) (1)
[Exocrine function of pancreas in chronic hypocalcemia. Studies in parathyroidectomized rats (author's transl)]. (1975) (1)
[Clinical pharmacology of high-dose furosemide in terminal renal insufficiency]. (1971) (1)
Renal and hepatic uptake of biologically active intact parathyroid hormone. (1987) (1)
Decreased cAMP content of the hypothalamus of genetically hypertensive rats (1978) (1)
Effect of serine on gluconeogenic ability of hepatocytes in acute uremia. (1983) (1)
The Effect of Nifedipine on Blood Hormones and Metabolic Intermediates in Hypertensive Patients Undergoing Regular Haemodialysis Treatment (1985) (1)
Long-term outcome in diabetic patients on hemodialysis treatment. (1989) (1)
Evidence for the role of proteinases in uremic catabolism. (1988) (1)
Phospholipase A in severely ill patients. (1989) (1)
Altered cyclic AMP levels in specific cardiovascular brain centers of spontaneously hypertensive rats (SHR) (1980) (1)
Acrylamide – no Evidence for Accumulation in End-Stage Renal Disease Patients Using Its Hemoglobin Adduct as Biomarker (2004) (1)
[Pupillary reaction on tyramine- a parameter of uremic sympathicopathy (author's transl)]. (1976) (1)
Effect of Verapamil on ionized calcium excretion in human parotid saliva (1979) (1)
Glycerol-induced acute renal failure in the rat: protection by exercise. (1987) (1)
[Therapy of lactate acidosis]. (2008) (1)
[The effect of mainly alpha-adrenergic drugs, indirect sympathomimetrics and dopamine on exocrine pancreatic function. Studies in the isolated cat pancreas (author's transl)]. (1978) (1)
[Vitamin B6-deficiency and -substitution in chronic uremia (author's transl)]. (1975) (1)
Stimulation of the sympathico-adrenergic (SAS) and renin-angiotensin-system (RAS) in hypertensive crisis (1979) (1)
Fibronectin metabolism in isolated glomeruli from obese Zucker rats. (1992) (1)
Pharmacokinetics of the loop diuretic piretanide in renal failure (2004) (1)
Norepinephrine Induced Renal Failure: Beneficial Effects of Atrial Natriuretic Factor (1986) (1)
Acute uremia following dietary potassium depletion. I. Effect on blood parameters related to carbohydrate metabolism. (1986) (1)
A subcutaneous arteriovenous fistula for use in intermittent haemodialysis. (1967) (1)
Granulocyte lysosomal factors and plasma elastase in uremia: A potential factor of catabolism (1984) (1)
[The importance of overweight and obesity for the development and progression of renal diseases]. (2004) (1)
[Stress, emotion and hypertension: the integrative role of central nervous system (author's transl)]. (1981) (1)
Proteases II (1988) (1)
[The importance of amino acid substitution for the protein metabolism in patients treated by periodical hemodialysis]. (1973) (1)
Parotid kallikrein secretion in the rat after alterations of electrolyte transport and cAMP activity. (1985) (1)
Eglin C fails to reduce catabolism in acutely uremic rats. (1988) (1)
Enhanced Parotid Kallikrein Secretion in Essential, Adrenal Hypertension and in Advanced Renal Failure — Inverse Relationship to Sodium Excretion (1980) (1)
Renal insufficiency : Würzburg Symposium, November 1974 (1976) (0)
Continuous and discontinuous ionography of the pancreatic juice and the parotid saliva using carrier-membrane disc-electrodes. (1980) (0)
Diabetes and the kidney (1989) (0)
THE EFFECT OF WHOLE-BODY RADIATION ON THE HEMODYNAMICS AND THE ELECTROCARDIOGRAM OF THE DOG (1963) (0)
Mechanisms of Genetic Renal Disease and Identification of Novel Disease Genes (1999) (0)
Contents Vol. 25, 1999 (1999) (0)
Pathophysiology and treatment of hypertension in dialysis patients. (1989) (0)
[Differential diagnostic aspects of pyelo- and glomerulonephritis. Urine and functional diagnosis]. (1970) (0)
ASS bei Niereninsuffizienz (1999) (0)
Author and Subject Index (1998) (0)
Subject Index, Vol. 13, 1993 (1993) (0)
Subject Index Vol. 68, 1994 (1994) (0)
Reduced Circulating AGE Levels and Lower Genomic Damage in Patients Undergoing Daily versus Standard Hemodialysis (2005) (0)
Professor Tadeusz Orlowski – one of the pioneers in European nephrology and transplantation (2009) (0)
[Duration of the electrical systole in progressive experimental hypokalemia]. (1962) (0)
Effect of COMT-inhibition on the renal excretion of (±)-adrenaline in dogs (2004) (0)
[ENZYME ACTIVITIES IN THE LIVER IN ACUTE EXPERIMENTAL HYPOKALEMIA]. (1963) (0)
Subject Index, Vol. 9, 1989 (1989) (0)
[Hemodynamic changes with oxgygen breathing]. (1960) (0)
[Effect of essential amino acids and their analogs in chronic kidney failure]. (1976) (0)
Hormonal and metabolic derangements in renal failure : Dialysis workshop, Grainau, March 21-23, 1985 (1986) (0)
[Lowered intrarenal protein degradation--an alternative path to glomerulosclerosis and tubulo-interstitial fibrosis]. (2000) (0)
[On renal potassium retention after administration of Amiloride HCl]. (1967) (0)
[Distribution space and elimination of 3H-methylguanidine in experimental uremia in the rat]. (1974) (0)
The influence of various volume expanders on renal function during hypo- and normovolemia. (1969) (0)
[Renoparenchymal hypertension. Is there a specific therapy?]. (2008) (0)
[Determination of glomerular filtration rate in man using single shot piracetam clearance]. (1992) (0)
[Progression of chronic renal failure. Pathogenesis and therapeutic aspects]. (1989) (0)
Effect of guanfacine on vigilance. (1980) (0)
[Fat and renal failure--therapeutic aspects]. (1982) (0)
[Clinical and experimental studies on the phenacetin kidney]. (1967) (0)
Hemorheology and Hypertension in End-Stage Renal Failure Patients Treated with Erythropoietin (1989) (0)
[QUANTITATIVE DETERMINATION OF URINE CONCENTRATION DISORDERS IN PYELONEPHRITIS]. (1965) (0)
Regulation of parotid kallikrein secretion-role of the alpha 2- and beta-adrenergic system. (1986) (0)
[The age factor in renal hemodynamics]. (1962) (0)
[Proceedings: Hemo- and crossdialysis treatment of phalloidine intoxication of awake rats]. (1974) (0)
[Importance of postoperative parenteral feeding--measured by low and high-molecular plasma proteins]. (1975) (0)
Subject Index, Vol. 8, 1988 (1988) (0)
Title Pages / Contents (1999) (0)
[Intratubular beta-glucuronidase concentration in various states of diuresis]. (1965) (0)
[Investigations on the performance of calcium selective disc-electrodes with electrically charged and neutral ligands in anaerobic serum measurements (author's transl)]. (1978) (0)
[Effects of uremia on neuronal uptake and liberation of norepinephrine]. (1973) (0)
Professor Tadeusz Orlowski, 80 years (1998) (0)
[Electrocardiographic features of acute potassium intoxication in patients with parenchymal liver damage]. (1961) (0)
[Excretion of mono- and bivalent ions in the pancreatic juice in experimental uremia. Studies in 5-6 nephrectomized rats]. (1972) (0)
[EFFECT OF ACUTE POTASSIUM DEPRIVATION CAUSED BY HEMODIALYSIS ON THE POTASSIUM CONTENT OF THE MYOCARDIUM AND OTHER TISSUES]. (1963) (0)
[The effect of total body irradiation on renal hemodynamics in an acute experiment]. (1961) (0)
[THE CARDIAC ENGORGED KIDNEY]. (1965) (0)
[Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)]. (1982) (0)
[Renal magnesium excretion in changed diuresis]. (1971) (0)
[Exocrine pancreatic function and calcium balance. Experimental studies of the effect of parathyroid hormone, vitamin D3, 25-hydroxycholecalciferol, dihydrotachysterin and thyrocalcitonin (author's transl)]. (1975) (0)
Hypercalciuria after diphenylhydantoin: a study of calcium metabolism in rats. (1977) (0)
Contents, Vol. 8, 1988 (1988) (0)
Subject Index, Vol. 3, 1985 (1985) (0)
Announcements – Book Review (2000) (0)
Contents, Vol. 5, 1987 (1987) (0)
Shaul G. Massry, Los Angeles, USA (1996) (0)
Use of proteolytic enzymes and of rutoside for the prevention or treatment of transplant rejection (1997) (0)
[Enzyme activity of the kidneys in acute experimental hypokalemia]. (1963) (0)
[Diagnostic relevancy of saralasin in renin-dependent hypertension]. (1976) (0)
Increased micronucleus frequencies in lymphocytes of patients with pre-endstage renal failure and in longterm hemodialysis therapy (1999) (0)
Removal of ages by hemodialysis, hemodia-filtration and hemofiltration A comparison (1999) (0)
Proteases and antiproteases at different vascular sites in renal failure. (1988) (0)
Nephrotoxic Serum Nephritis: Possible Role of Intraglomerular Proteinases in Progressive Glomerulosclerosis1 (1993) (0)
Increased organ levels of angiotensin II in ren2 rats leads to the formation of reactive oxygen species and DNA damage (2012) (0)
Contents, Vol. 35, 1983 (1983) (0)
[Distribution of electrolytes and substances normally contained in urine in the extracellular space under dialysis]. (1968) (0)
[Renal excretion and renal metabolism of DL-adrenaline]. (1971) (0)
Effect of COMT-inhibition on the renal excretion of (plus or minus)-adrenaline in dogs. (1974) (0)
The uraemic sympathicopathy in vitro and in vivo. (1973) (0)
[Divergence of renal sodium and magnesium excretion following administration of trometamol (trisbuffer), amiloroide-HCL, acetazolamide and parathormone -- a result of urinary alkalization?]. (1970) (0)
[Relations between effective renal plasma flow and active plasma volume]. (1962) (0)
MEASUREMENT OF GLOMERULAR FILTRATION RATE IN PATIENTS WITH DIABETES MELLITUS TYPE1 (2001) (0)
ffect of Different Hemodialysis Regimens on enomic Damage in End-Stage Renal Failure (2006) (0)
[Erythropoietin, aluminum and renal anemia]. (1990) (0)
Contents, Vol. 14, 1994 (1993) (0)
[Salidiuretic therapy of renal tubular acidosis and its complications]. (1972) (0)
The effect of hormonal contraceptives on electrolyte excretion of human parotid saliva (1980) (0)
53 Alterations in the central atrial natriuretic factor system in young (prehypertensive) spontaneously hypertensive rats (1988) (0)
Suppression of immunoglobulin and interleukin-6 production from peripheral blood mononuclear cells by dialysis membranes. (1990) (0)
[Incorporation of 45Ca into the myocardium and aorta in experimental uremia]. (1974) (0)
[Hypercalciuria--nephrocalcinosis-- and calcium calculi of the kidney. Differential diagnosis and clinical aspects of pathological renal calcium transport]. (1974) (0)
Contents, Vol. 68, 1994 (1994) (0)
Subject Index, Vol. 35, 1983 (1983) (0)
Erythropoietin, Blood Viscosity, and Hypertension: Implications for Patients with End-Stage Renal Disease (1989) (0)
Effect of cyclosporin A, azathioprine, and prednisolone on carbohydrate metabolism of rat hepatocytes (1990) (0)
Clinical experience with recombinant human erythropoietin in hemodialysis patients. (1988) (0)
Th-P16:362 Rosuvastatin reduces oxidative stress and DNA damage in human promyelocytic HL-60 cells (2006) (0)
Calcium antagonists and the kidney--what are the perspectives in 1994? (1994) (0)
Carbohydrate metabolism of salivary glands of acutely uremic rats. (1983) (0)
[Effect of angiotensin II on electrolyte and protein excretion in the submandibular gland of the cat]. (1974) (0)
Advanced Glycation End Product-Induced DNA Damage: Involvement of Angiotensin II (2005) (0)
Do different haemodialysis regimen interfere with genomic damage in patients with end-stage-renal disease? (2006) (0)
[Possible clinical importance of the activation of diamine oxidase (histaminase) in heparin treatment of renal diseases (author's transl)]. (1978) (0)
Contents, Vol. 51, 1990 (1990) (0)
Diabetes mellitus - clinical studies - 2 (2009) (0)
Advanced glykation end products in patients with liver cirrhosis before and after liver transplantation (2002) (0)
Subject Index Vol. 50, 1988 (1988) (0)
Subject Index Vol. 50, 1988 (1988) (0)
Subject Index, Vol. 5, 1987 (1987) (0)
[Cardiac glycosides and uremia]. (1976) (0)
[Vasodilatation in renal ischemia with myogen]. (1962) (0)
[Effects of proteolytic enzymes on advanced glycation end-products (AGEs): possible clinical implications]. (2008) (0)
Mechanism of action of atrial natriuretic peptides does not involve adenylate cyclase system of different rat brain areas. (1988) (0)
Abstracts of The Japanese Journal of Nephrology (1980) (0)
[Clinical experimental studies on renal phenolsulfonphthalein transport]. (1968) (0)
[Diabetic nephropathy: new findings on pathogenesis and therapy]. (2000) (0)
Guidelines for the Dosage and Application of the Intravenous Provision of Nutrient Substances in Patients with Renal Failure (1976) (0)
[Significance of the kidney in blood volume regulation]. (1968) (0)
[Pulmonary renal syndrome. Favorable prognosis of immunologically mediated diseases through adequate diagnosis and therapy]. (2008) (0)
[Therapy of rapidly progressive glomerulonephritis]. (1982) (0)
Enzyme cytochemistry of rat organs after uremia with special reference to proteases (2004) (0)
288 SHORT- AND LONG-TERM RESULTS OF HIGH-TONE EXTERNAL MUSCLE STIMULATION IN SYMPTOMATIC DIABETIC AND UREMIC PERIPHERAL POLYNEUROPATHY IN END-STAGE RENAL DISEASE (2010) (0)
Acute uremia following dietary potassium depletion. II. Effect on tissue carbohydrate composition. (1987) (0)
Hypercalciuria after Diphenylhydantoin (1977) (0)
New aspects in release of atrial natriuretic peptide. Role of calcium and parathyroid hormone. (1990) (0)
[Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)]. (1977) (0)
Role of proteases in patients with acute renal failure and regular hemodialysis therapy. (1988) (0)
[The behavior of filtered plasma fractions in patients undergoing unilateral nephrectomies]. (1965) (0)
[Calcium and magnesium excretion following hypertonic saline administration in arterial hypertension]. (1969) (0)
[Use of various methods of dialysis in intensive care patients]. (1989) (0)
[Phosphate and uric acid transport in terminal kidney failure]. (1968) (0)
[Effect of the so-called uremia toxins on exocrine pancreas function]. (1974) (0)
[Behavior of blood potassium in acute potassium loss caused by extracorporeal dialysis]. (1961) (0)
[Renal extraction of PAH in experimental change of renal circulation]. (1965) (0)
[Hemo and cross dialysis treatment in phalloidin intoxication in the waking rat]. (1975) (0)
[Sympathicomimetic circulatory reaction in hemorrhagic collapse in the dog and its influence on the electrocardiogram]. (1962) (0)
Enzyme therapy in diabetic nephropathy: Experimental and initial clinical data (2001) (0)
Abnormal Adhesion of T Cells to Extracellular Matrix Proteins in Hemodialysis Patients (1998) (0)
[Nephrotic syndrome of the adult. 1]. (1971) (0)
[Hemoperfusion--calculated risk]. (1976) (0)
Intraglomerular protein accumulation in chronically rejected human kidney allografts. (1996) (0)
[Proceedings: Chemistry of saliva and catecholamine content of adrenergic nerves of the parotid gland in chronic parotitis and Sjögren's syndrome]. (1973) (0)
[Blood volume, serum electrolytes and albumin following infusion of pasteurized plasma]. (1965) (0)
Use of proteolytic enzymes to prevent or treat graft rejection (1997) (0)
[THE EFFECT OF TOTAL BODY IRRADIATION ON THE HEMODYNAMICS AND THE ELECTROCARDIOGRAM IN DOGS]. (1963) (0)
Subject Index Vol. 51, 1990 (1990) (0)
[Bone collagen metabolism in uremia--studies of plasma hydroxyproline level in chronic, non-dialyzed kidney disease]. (1975) (0)
[Dietary measures for preventing the progression of chronic renal failure]. (1989) (0)
Protease histochemistry in normal and uremic rats. (1988) (0)
[Fundus hypertonicus malignus. Increased incidence in renal parenchymal diseases]. (1986) (0)
[Saliva electrolytes and flow rate in terminal kidney insufficiency]. (1971) (0)
The Role of Proteolytic Enzymes in the Treatment of Acute Hepatic Failure with Plasmapheresis (1983) (0)
[Effects of diuretics after pretreatment with reserpine and 6-OH-dopamine (author's transl)]. (1976) (0)
[Diagnosis and therapy of pyelonephritis and glomerulonephritis]. (1978) (0)
[Activation of the sympathico-adrenal system following the administration of diuretics--relationship to saluretic effect and glomerular filtration rate]. (1969) (0)
[The behavior of edema during dialysis]. (1968) (0)
[Renal hemodynamics in compensated and severely decompensated hypertension]. (1962) (0)
The Joint Society of Nephrology in Germany, Switzerland and Austria - Five Decades of Successful Activities. (2016) (0)
[Pheochromocytoma-like symptoms in acute hypertensive encephalopathy]. (1978) (0)
[Renal magnesium transport in glomerulonephritis and pyelonephritis with special emphasis on the terminal stage]. (1971) (0)
Consultants for the American Journal aof Nephrology 1998 (1998) (0)
CLINICAL ASPECTS OF COCCIDIOIDOMYCOSIS (1966) (0)
[Toxic kidney damage]. (1989) (0)
Contents, Vol. 3, 1985 (1985) (0)
Contents, Vol. 7, 1989 (1989) (0)
[Renal osteodystrophy]. (1974) (0)
[Urinary leukocyte casts in glomerulonephritis--a symptom of secondary pyelonephritis]. (1970) (0)
[Methylguanidine and excretory pancreatic function: a model for uraemic pancreatic disease? (author's transl)]. (1974) (0)
[The effect of diphenylhydantoin on exocrine pancreatic function (author's transl)]. (1974) (0)
DOES DAILY HEMODIALYSIS IMPROVE GENOMIC DAMAGE IN DIALYSIS PATIENTS (2004) (0)
Low-density lipoprotein suppresses cathepsins B and L activity in rat mesangial cells. (1996) (0)
Henri Jahn (1923–1994) (1994) (0)
Subject Index Vol. 25, 1999 (1999) (0)
Subject Index, Vol. 7, 1989 (1989) (0)
[Toxic nephropathies (author's transl)]. (1980) (0)
[Acetylsalicylic acid in renal failure]. (1998) (0)
Abstract of the 68th Meeting (Spring Meeting) 6–9 March 1990, Heidelberg (1990) (0)
[Disturbances of the complement system in renal failure and the influence of amino acid substitution (author's transl)]. (1974) (0)
[Follow-up studies in late gestoses]. (1967) (0)
Effect of the ACE-Inhibitor Enalapril on Plasma Concentration of Atrial Natriuretic Peptide and on Glomerular Filtration Rate in Normotensive and Hypertensive Diabetic Rats (1991) (0)
Contents Vol. 87, 2001 (2001) (0)
Effects of acute hemodialysis-induced changes in sodium balance on the renin-angiotensin system in renovascular and spontaneously hypertensive rats (1979) (0)
WORLD KIDNEY FORUM Renal Research in 19th Century Germany (2010) (0)
Growth promoter-induced inhibition of proteolytic activities in cultured kidney cells: potential impact in diabetic nephropathy. (1996) (0)
[Kidney function and peripheral venous pressure with oxygen breathing in cardiac decompensation]. (1960) (0)
Diagnostische Strategien bei Abstoßungsreaktionen nach Nierentransplantation (1991) (0)
Early functional effects of various antihypertensive drugs in chronically uremic rats. (1988) (0)
Haemodialysis-induced pulmonary leucocyte sequestration in the rabbit. (1983) (0)
[Intraneuronal metabolism of noradrenaline in experimental uremia and hypertension]. (1974) (0)
[Acute and chronic effect of high-dose diuretics in terminal kidney failure]. (1968) (0)
Excretion of the mono- and divalent ions in relation in relation to flow rate in Bartter's and pseudo Bartter's syndromes in parotid saliva. Comparative studies to the syndrome of Conn. (1972) (0)
[Partial kidney function in experimental hemorrhagic hypotension]. (1967) (0)
Impaired hormonal stimulation in isolated hepatocytes of phosphorous depleted rats. (1984) (0)
57 Hypertension in Patients with Glomerulonephritis - Dependence on Renal Disease, Age and Renal Function (1984) (0)
The Influence of Diuretics on the Fractional Fluid and Electrolyte-Excretion in Renal Insufficiency (1969) (0)
Title Page / Contents / Introduction (1978) (0)
Contents, Vol. 9, 1989 (1989) (0)
[New aspects in diagnosis of proteinuria]. (1992) (0)
[Hemo- and cross dialysis of phalloidine poisoning in the conscious rat]. (1974) (0)
[PP.02.25] TREATMENTS OF RESISTANT PERIPHERIC POLYNEUROPATHIES WITH DIABETES MELLITUS, CHRONIC KIDNEY DISEASE PRIMARY HYPERTENSION. HIGH TONE ELECTRICAL MUSCLE STIMULATION-HTEMS (2017) (0)
[Psychoneuroimmunology: impact of the nervous system on the immune system]. (1989) (0)
Prostaglandin synthetase inhibitors are not beneficial in the hypercatabolic state of acute uremia in rats (1988) (0)
[RENAL HEMODYNAMICS AND ELECTROLYTE EXCRETION IN ORTHOSTASIS]. (1964) (0)
[Proceedings: Autonomous insufficiency in dialysis patients]. (1975) (0)
[Possibilities and limitations of high dosage diuretic therapy in hydropic renal insufficiency]. (1969) (0)
Calcium antagonists in the treatment of hypertension. (1982) (0)
Kallikrein excretion in parotid saliva in rats with various forms of arterial hypertension (2004) (0)
[Behavior of the sympathicoadrenal system following intravenous administration of diuretics]. (1969) (0)
Subject Index Vol. 87, 2001 (2001) (0)
Chronic kidney allograft rejection is accompanied by increased urinary excretion of fibronectin. (2000) (0)
Consultant List (2002) (0)
[Cardiorenale hemodynamics in cardiac insufficiency. Relation between reduced renal blood flow and hypovolemia]. (1972) (0)
LaudatioJoel D. Kopple (1998) (0)
[PYELONEPHRITIS AND HYPERTENSION]. (1964) (0)
[Guanfacinum (BS 100-14) in long-term therapy of severe hypertension]. (1977) (0)
Subject Index, Vol. 6 (Suppl. 1), 1986 (1986) (0)
Subject Index Vol. 14, 1994 (1994) (0)
[Erythropoietin, blood viscosity and hypertension in chronic kidney failure]. (2009) (0)
[Pseudohypocalcemia in heparinized blood]. (1961) (0)
[Studies of renal phosphate transport in essential and renovascular hypertension, pyelonephritis and glomerulonephritis]. (1971) (0)
[Blood picture, blood volume and diuresis in pyrazolone-pyrazolidine therapy]. (1961) (0)
Diabetic nephropathy: new pathogenetic aspects. (1989) (0)
[Ionized calcium and total calcium of parotid saliva in normotension and in arterial hypertension (author's transl)]. (1978) (0)
[CONTINUOUS VENOUS PRESSURE MEASUREMENT AS A POSSIBILITY OF HEMODYNAMIC SUPERVISION IN EXTRACORPOREAL HEMODIALYSIS]. (1965) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With August Heidland?

August Heidland is affiliated with the following schools:

University of Würzburg

August Heidland's Academic­Influence.com Rankings

Why Is August Heidland Influential?

August Heidland's Published Works

Published Works

What Schools Are Affiliated With August Heidland?

August Heidland's AcademicInfluence.com Rankings